A. Hiratsuka et al., INACTIVATION OF CONSTITUTIVE HEPATIC CYTOCHROMES P450 BY PHENCYCLIDINE IN THE RAT, Drug metabolism and disposition, 23(2), 1995, pp. 201-206
The purpose of this study was to determine whether phencyclidine (PCP)
inhibits constitutive hepatic cytochrome P450 (CYP) isozymes when adm
inistered to naive adult male Sprague-Dawley rats. Animals were pretre
ated with PCP (25 mg/kglday for 2 days), killed 3 and 16 hr after the
last dose, and liver microsomes prepared. The washed microsomes were t
hen assayed for benzphetamine, methamphetamine (MA), and methylenediox
ymethamphetamine (MDMA) N-demethylation together with MDMA demethylena
tion and MA 4-hydroxylation activities, MDMA demethylenation (low subs
trate concentration), MA 4-hydroxylation, and metoprolol alpha-hydroxy
lation reactions, which are catalyzed by CYP2D isozymes, were reduced
>74% 3 hr after the last PCP dose and were only partially restored 13
hr later. Benzphetamine and (-)-MDMA N-demethylation activities were r
estored to control values 16 hr after the last dose. These results ind
icate that PCP suppresses constitutive isozymes, including CYP2C11 and
members of the CYP2D subfamily. The suppression of cytochromes P450 a
ctivity by PCP in vivo is consistent with its in vitro actions found i
n this and other studies, and demonstrates that alteration of CYP acti
vity is another pharmacological effect of this compound.